Magnesium sulfate
Pregnancy & gynaecology-specific. Every dose row is source-referenced; verify against institutional protocols.
Magnesium sulfateEMERGENCY KITAnticonvulsant/uterorelaxant
Regimens checked: 2026-10-17. Each indication has its own preparation, limits and safety checks.
| Indication | Dose | Route | Frequency | Duration / preparation | Maximum | Monitoring / cautions |
|---|---|---|---|---|---|---|
Eclampsia: stop seizures and prevent recurrence | 4 g IV loading, then 5 g deep IM into EACH buttock (10 g IM total); maintenance 5 g IM into alternate buttocks | IV loading + deep IM | Loading once; maintenance every 4 hours | Continue until 24 hours after birth OR the last seizure, whichever is later · Using 50% (500 mg/mL): 4 g = 8 mL; dilute in 100 mL sodium chloride 0.9% and infuse over 15–20 min. Each 5 g IM dose = 10 mL of 50% solution. Check the actual ampoule strength. | Do not give maintenance when toxicity criteria are present; do not run an additional magnesium regimen | Monitor
|
Eclampsia: alternative when a reliable infusion pump and monitoring are available | 4 g IV loading over 15–20 min, then 1 g/hour | IV infusion | One loading dose, then continuous infusion | 24 hours after birth or last seizure, whichever is later · 50% solution: withdraw 8 mL (4 g) into 100 mL sodium chloride 0.9% for loading; for maintenance make 20 g up to a FINAL 100 mL (200 mg/mL), run at 5 mL/hour by labelled pump
| Use ONE IV or IV/IM protocol; stop/adjust for toxicity or renal dysfunction | Monitor
|
Recurrent eclamptic convulsion after loading; reassess airway, glucose and magnesium toxicity | 2 g IV additional dose after senior assessment | IV infusion | One rescue dose, followed by reassessment | Acute rescue; continue the selected maintenance regimen · 50% solution: 2 g = 4 mL, dilute in compatible sodium chloride 0.9%; give slowly by infusion and check the total loading already received | MSF ceiling: no more than 8 g IV in the first hour; persistent fits need anaesthesia/ICU, not repeated blind magnesium dosing | Monitor
|
Imminent preterm birth: NICE offers at 24+0–29+6 weeks and considers at 30+0–33+6 weeks; discuss 23+0–23+6 individually | 4 g over 15 min, then 1 g/hour | IV infusion | Loading once, then continuous infusion | Stop at birth or 24 hours, whichever occurs first · 50%: 4 g = 8 mL diluted in compatible sodium chloride 0.9%; maintenance example 20 g made up to FINAL 100 mL, 5 mL/hour via pump | 24 hours for neuroprotection; do not add to an eclampsia regimen already running | Monitor
|
Pregnancy safety
Standard of care in pregnancy for above indications
Lactation
Compatible
Trimester notes
All trimesters when indicated
Adverse effects
Flushing, weakness, diplopia, respiratory depression, cardiac arrest at toxic levels
MSFcheckedIN REVIEW